awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36941966-11C7D934-ECA2-4517-A00B-3DE59007318E
Q36941966-11C7D934-ECA2-4517-A00B-3DE59007318E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36941966-11C7D934-ECA2-4517-A00B-3DE59007318E
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer
P2860
Q36941966-11C7D934-ECA2-4517-A00B-3DE59007318E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36941966-11C7D934-ECA2-4517-A00B-3DE59007318E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d87fa5ad5a037790551286e1c1d385bffda60cc5
P2860
An update on PARP inhibitors--moving to the adjuvant setting.